1 - 8 of
8 for companies in
Israel:
Aposense is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents based on the identification and targeting of cells undergoing apoptosis (programmed cell death).
A drug development company that has developed an innovative, nanotechnology-based system called NEOWATER. NEOWATER is a commercially available broad enabling platform upon which research, diagnostics, biotech and pharma companies can obtain disruptive price-performance results and overcome current technology barriers with an elegant implementation.
Develops advanced biosensors, based on multidisciplinary knowledge in bio- and nanotechnology.
Nanolymf Ltd. is a subsidiary of Shizim Ltd. with the mission to meet the challenges of enhancing the bioavailability of highly lipophilic drugs, by introducing the market with a novel controlled release double layered nanoencapsulation delivery system.
NST is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents (ApoSense - a small molecule 'Interfacial Nanoswitch') based on the identification and targeting of cells undergoing apoptosis.
Develops nano-encapsulation technology for delivery applications for nutraceuticals and drugs.
The company's technology involves the encapsulation, at room temperature, of active ingredients in micro- and nano-sized glass (silica) matrices as well as nanospheres utilizing a chemical process called sol-gel.
A drug delivery company developing enhanced and improved therapeutic medicines in several fields. Solubest is using advanced polymer formulations to prepare nanotransporters for drugs having delivery or compliance insufficiencies.
[First Page] [Prev] Showing page 1 of 1 pages [Next] [Last Page]
